At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results